Carbon monoxide decreases perfusion pressure in isolated human placenta

被引:53
作者
Bainbridge, SA
Farley, AE
McLaughlin, BE
Graham, CH
Marks, GS
Nakatsu, K
Brien, JF
Smith, GN
机构
[1] Queens Univ, Fac Hlth Sci, Dept Anat & Cell Biol, Kingston, ON, Canada
[2] Queens Univ, Fac Hlth Sci, Dept Pharmacol & Toxicol, Kingston, ON, Canada
[3] Queens Univ, Fac Hlth Sci, Dept Obstet & Gynecol, Kingston, ON, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1053/plac.2002.0845
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Carbon monoxide (CO) is one of the metabolites formed via heme oxidation catalysed by the enzyme herne oxygenase (HO). Endogenous formation of CO, mediated by HO, has been noted in both placental and umbilical vessels. In blood vessels from different mammalian sources, it has been proposed that the vasodilator effect of CO is mediated via stimulation of soluble guanylyl cyclase (sGC) and consequent increased cGMP formation. The purpose of the present study was to determine the effect of exogenous CO on placental cotyledon perfusion pressure and to determine the role of sGC in the CO-induced decrease of perfusion pressure using the in vitro human placental perfusion preparation. A thromboxane A2 mimetic (U46619) was added to the foetal perfusion medium to constrict the placental blood vessels. Carbon monoxide was added to the foctal perfusion medium in increasing concentrations to determine its effect on placental perfusion pressure. Carbon monoxide produced a concentration-dependent decrease in placental perfusion pressure. The addition of ODQ a sGC inhibitor, attenuated the CO-induced decrease in placental perfusion pressure, while addition of YC-1, an activator of sGC, augmented the CO-induced decrease in placental perfusion pressure. The data indicate that CO causes vasorelaxation of placental resistance blood vessels, in large part, via activation of sGC. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:563 / 569
页数:7
相关论文
共 34 条
[1]   Induction of placental heme oxygenase-1 is protective against TNFα-induced cytotoxicity and promotes vessel relaxation [J].
Ahmed, A ;
Rahman, M ;
Zhang, X ;
Acevedo, CH ;
Nijjar, S ;
Rushton, I ;
Bussolati, B ;
St John, J .
MOLECULAR MEDICINE, 2000, 6 (05) :391-409
[2]  
Appleton SD, 1999, DRUG METAB DISPOS, V27, P1214
[3]   STUDIES OF THE HEME COORDINATION AND LIGAND-BINDING PROPERTIES OF SOLUBLE GUANYLYL CYCLASE (SGC) - CHARACTERIZATION OF FE(II)SGC AND FE(II)SGC(CO) BY ELECTRONIC ABSORPTION AND MAGNETIC CIRCULAR-DICHROISM SPECTROSCOPIES AND FAILURE OF CO TO ACTIVATE THE ENZYME [J].
BURSTYN, JN ;
YU, AE ;
DIERKS, EA ;
HAWKINS, BK ;
DAWSON, JH .
BIOCHEMISTRY, 1995, 34 (17) :5896-5903
[4]  
BUSTARD MA, 2002, IN PRESS AM J OBSTET
[5]  
Christova T, 2000, Acta Physiol Pharmacol Bulg, V25, P9
[6]   Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme [J].
Friebe, A ;
Schultz, G ;
Koesling, D .
EMBO JOURNAL, 1996, 15 (24) :6863-6868
[7]  
GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184
[8]   Heme oxygenase and carbon monoxide:: Regulatory roles in islet hormone release -: A biochemical, immunohistochemical, and confocal microscopic study [J].
Henningsson, R ;
Alm, P ;
Ekström, P ;
Lundquist, I .
DIABETES, 1999, 48 (01) :66-76
[9]   Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system:: stimulation by YC-1, nitric oxide, and carbon monoxide [J].
Hoenicka, M ;
Becker, EM ;
Apeler, H ;
Sirichoke, T ;
Schröder, H ;
Gerzer, R ;
Stasch, JP .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (01) :14-23
[10]   The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate [J].
Hussain, AS ;
Marks, GS ;
Brien, JF ;
Nakatsu, K .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (08) :1034-1037